Intra-Cellular Therapies Shares Plunge After Disappointing Drug Trial Results

Intra-Cellular Therapies said its lead drug candidate had a similar rate of effectiveness to placebo in a Phase 3 schizophrenia trial.

from WSJ.com: US Business http://ift.tt/2cWIzvC
via IFTTT